- Home
- EXEL vs UNM Comparison
EXEL vs UNM Comparison
Compare EXEL & UNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- UNM
- Stock Information
- Founded
- EXEL 1994
- UNM 1848
- Country
- EXEL United States
- UNM United States
- Employees
- EXEL N/A
- UNM N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- UNM Accident &Health Insurance
- Sector
- EXEL Health Care
- UNM Finance
- Exchange
- EXEL Nasdaq
- UNM Nasdaq
- Market Cap
- EXEL 12.0B
- UNM 14.4B
- IPO Year
- EXEL 2000
- UNM 1986
- Fundamental
- Price
- EXEL $45.40
- UNM $80.73
- Analyst Decision
- EXEL Buy
- UNM Buy
- Analyst Count
- EXEL 18
- UNM 13
- Target Price
- EXEL $44.29
- UNM $88.85
- AVG Volume (30 Days)
- EXEL 2.7M
- UNM 1.1M
- Earning Date
- EXEL 07-28-2025
- UNM 07-29-2025
- Dividend Yield
- EXEL N/A
- UNM 2.08%
- EPS Growth
- EXEL 237.58
- UNM 26.80
- EPS
- EXEL 2.20
- UNM 8.54
- Revenue
- EXEL $2,298,922,000.00
- UNM $12,778,600,000.00
- Revenue This Year
- EXEL $9.93
- UNM $4.30
- Revenue Next Year
- EXEL $13.17
- UNM $3.90
- P/E Ratio
- EXEL $20.60
- UNM $9.46
- Revenue Growth
- EXEL 24.49
- UNM 1.82
- 52 Week Low
- EXEL $22.20
- UNM $51.80
- 52 Week High
- EXEL $49.62
- UNM $84.48
- Technical
- Relative Strength Index (RSI)
- EXEL 57.52
- UNM 51.61
- Support Level
- EXEL $43.86
- UNM $79.69
- Resistance Level
- EXEL $45.52
- UNM $81.59
- Average True Range (ATR)
- EXEL 1.44
- UNM 1.43
- MACD
- EXEL -0.07
- UNM -0.02
- Stochastic Oscillator
- EXEL 39.60
- UNM 42.31
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About UNM Unum Group
Unum Group is a provider of group and individual income protection insurance products in the United States, the United Kingdom, Poland, and other countries. It is the domestic disability insurer, with the majority of premiums generated from employer plans. The company also offers a complementary portfolio of other insurance products, including long-term care insurance, life insurance, and employer- and employee-paid group benefits. It has the following operating business segments: Unum USA, Unum International, Closed Block, Colonial Life, and Corporate. The majority of the revenue is earned from the Unum USA segment. The firm markets its products through brokers.